Stock Financial Ratios


NATR / Nature's Sunshine Products, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price12.75
Volume51,700.00
Market Cap ($M)230.47
Enterprise Value ($M)172.80
Book Value ($M)132.40
Book Value / Share6.95
Price / Book1.69
NCAV ($M)142.54
NCAV / Share7.48
Price / NCAV1.50
Income Statement (mra) ($M)
Revenue341.16
EBITDA10.04
Net Income0.68
Balance Sheet (mrq) ($M)
Cash & Equivalents47.69
Cash / Share2.50
Assets222.21
Liabilities66.17
Quick Ratio0.83
Current Ratio1.59
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.00
Return on Assets (ROA)0.00
Return on Equity (ROE)0.01
Identifiers and Descriptors
CUSIP639027101
Central Index Key (CIK)275053
Industry Groups
SIC 2834 - Pharmaceutical Preparations
Share Statistics
Common Shares Outstanding (M)18.90
Scoring Models
Piotroski F Score5.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Cash And Equivalents Per Share2.50
Minority Interest Per Share0.03
Inventory Work In Progress Per Share0.00
Goodwill Per Share0.00
Debt Per Share0.00
Liabilities And Stock Equity Per Share11.66
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Intangibles Per Share0.05
Equity Per Share7.15
Liabilities Other Non Current Per Share0.06
Accounts Receivable Per Share0.57
Assets Per Share11.66
Assets Other Current Per Share0.00
Inventory Finished Goods Per Share0.00
Property Plant And Equipment Per Share3.68
Preferred Stock Value Outstanding Per Share0.00
Cash Per Share2.50
Accumulated Depreciation And Depletion Per Share0.00
Liabilities Per Share3.47
Property Plant And Equipment Gross Per Share0.00
Liabilities Current Per Share3.05
Assets Current Per Share6.00
Inventory Raw Materials Per Share0.00
Additional Paid In Capital Per Share0.00
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Accounts Payable Per Share0.00
Assets Non Current Per Share0.00
Property Plant And Equipment Net Per Share3.68
Retained Earnings Per Share0.80
Inventory Per Share2.59
Assets Other Non Current Per Share0.71

Related News Stories

Earnings Review and Free Research Report: The Medicines Reported Better Than Expected Earnings Results

2017-11-21 accesswire
LONDON, UK / ACCESSWIRE / November 21, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on The Medicines Co. (NASDAQ: MDCO), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=MDCO, following the Company's announcement of its financial results on October 25, 2017, for the third quarter of the fiscal year 2017. The biopharmaceutical Company's drug, Vabomere, was granted an accelerated approval by the US Food and Drug Administration (FDA). (40-0)

Nature's Sunshine Products' (NATR) CEO Greg Probert on Q3 2017 Results - Earnings Call Transcript

2017-11-09 seekingalpha
Greetings, and welcome to the Nature’s Sunshine Products Third Quarter 2017 Earnings Conference Call. All participants are in a listen-only mode and this conference is being recorded. I would now like to turn the conference over to your host, Mr. Richard Strulson, General Counsel and Chief Compliance Office of Nature Sunshine Products. Thank you. Mr. Strulson, you now have the floor. (2-0)

Nature's Sunshine Products' (NATR) CEO Greg Probert On Q2 2017 Results - Earnings Call Transcript

2017-08-09 seekingalpha
Greetings, and welcome to the Nature’s Sunshine Products Second Quarter 2017 Earnings Conference Call. All participants are in a listen-only mode and this conference is being recorded. I would now like to turn the conference over to your host, Mr. Nate Brower, Associate General Counsel of Nature’s Sunshine Products. Thank you. Mr. Brower, you now have the floor.

CUSIP: 639027101